The Russian team hopes to start mass production of its vaccine in October, far sooner than other leading scientists.
In shooting for such an ambitious schedule, Russia’s vaccine is jumping ahead of established pharmaceutical practice. Similar vaccines, such as one being developed by the University of Oxford and AstraZeneca, are still undergoing so-called phase three clinical trials and are not expected to be widely available until early 2021.
Employees wearing protective equipment at the production line of Russia's biotech company BIOCAD in May.The Russian vaccine, developed in cooperation between the Gamaleya Institute in Moscow and a Russian Defense Ministry laboratory, has completed phase one and two clinical trials with several small groups of volunteers. A larger trial, involving up to 1,600 people, will only begin this month after initial batches of the virus go into circulation.
In effect, Russia is conducting its phase three trials live, treating them more like a demonstrator group than a control group meant to ensure there’s nothing dangerous awaiting the larger population. Russia’s pharma industry is preparing to launch into mass production in September. If all goes well, Murashko said, mass vaccination awaits in October.
“They are accelerating the vaccine approval process, but it seems to me that the situation requires this,” says Tom Adshead, director of research at Macro-Advisory, a Moscow-based consulting firm.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Coronavirus tally: Gobal cases of COVID-19 top 19 million and U.S. death toll tops 160,000The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 19 million on Friday, according to data aggregated by Johns...
Weiterlesen »
Russia offers to supply Philippines with COVID-19 vaccineRussia is willing to supply a coronavirus vaccine to the Philippines, or team up with a local firm to mass produce it, its ambassador to Manila said on Friday, as infections in the Southeast Asian nation surge.
Weiterlesen »
5 former CDC directors on where US went wrong in its COVID-19 response'So, when you have political leaders and public health leaders coming at this with very different messaging, [and] when you don't see the political leadership supporting public health science, you lose trust.'
Weiterlesen »
Greatest COVID-19 threat to college football not on the field, according to studyThe greatest COVID-19 threat to college football players this fall might not be on the field, but rather on the rest of campus, a newly published study shows.
Weiterlesen »
Essential California: This county will pay COVID-19 patients to stay homeThe Alameda County Board of Supervisors has unanimously approved a pilot program to give some residents diagnosed with COVID-19 a $1,250 one-time stipend to stay home and quarantine.
Weiterlesen »